| Dr Rajat Suri, MD | |
|
200 W Arbor Dr, San Diego, CA 92103-9000 | |
| (800) 926-8273 | |
| (888) 539-8781 |
| Full Name | Dr Rajat Suri |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 9 Years |
| Location | 200 W Arbor Dr, San Diego, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144615337 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | A146658 (California) | Secondary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | A146658 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Uc San Diego Health Hillcrest - Hillcrest Med Ctr | San diego, CA | Hospital |
| Southwest Healthcare System | Murrieta, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regents Of The University Of California | 3577476761 | 1692 |
News Archive
Adding sulphonylureas (SUs) to metformin remains a commonly used strategy for treating type 2 diabetes, but individual SUs differ and may confer different risks of abnormally low blood sugar, or hypoglycemia. SUs-which include newer generation agents such as gliclazide, glipizide, glimepiride, and glibenclamide-stimulate the production of insulin in the pancreas and increase the effectiveness of insulin in the body.
After recent research from campaigning organization Greenpeace found the S-26 Soy brand of infant formula contains GM or genetically modified ingredients that are not disclosed on the product label, two Senators are urging the Federal Government to tighten Australia's food labeling laws.
A recent study published in the MDPI journal, Pathogens, describes a coronavirus peptide vaccine antigen in the form of nanodiamond-based formulations, that demonstrated a robust and long-lasting immune response. The nanodiamonds proved to be a powerful and versatile platform for antigen conjugation. This could make it a safe and effective strategy for the production of off-the-shelf vaccines against multiple coronaviruses.
A drug used for rheumatoid arthritis has moved a step closer to FDA approval for a desperately needed new use.
A Johns Hopkins study suggests that people with type I and type II diabetes would be well advised to monitor their blood sugar levels more than the usual twice daily to make sure that levels are not elevated over 150 milligrams per deciliter for sustained periods.
› Verified 5 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376646869 PECOS PAC ID: 3577476761 Enrollment ID: O20031112000695 |
News Archive
Adding sulphonylureas (SUs) to metformin remains a commonly used strategy for treating type 2 diabetes, but individual SUs differ and may confer different risks of abnormally low blood sugar, or hypoglycemia. SUs-which include newer generation agents such as gliclazide, glipizide, glimepiride, and glibenclamide-stimulate the production of insulin in the pancreas and increase the effectiveness of insulin in the body.
After recent research from campaigning organization Greenpeace found the S-26 Soy brand of infant formula contains GM or genetically modified ingredients that are not disclosed on the product label, two Senators are urging the Federal Government to tighten Australia's food labeling laws.
A recent study published in the MDPI journal, Pathogens, describes a coronavirus peptide vaccine antigen in the form of nanodiamond-based formulations, that demonstrated a robust and long-lasting immune response. The nanodiamonds proved to be a powerful and versatile platform for antigen conjugation. This could make it a safe and effective strategy for the production of off-the-shelf vaccines against multiple coronaviruses.
A drug used for rheumatoid arthritis has moved a step closer to FDA approval for a desperately needed new use.
A Johns Hopkins study suggests that people with type I and type II diabetes would be well advised to monitor their blood sugar levels more than the usual twice daily to make sure that levels are not elevated over 150 milligrams per deciliter for sustained periods.
› Verified 5 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386762300 PECOS PAC ID: 3577476761 Enrollment ID: O20040430001307 |
News Archive
Adding sulphonylureas (SUs) to metformin remains a commonly used strategy for treating type 2 diabetes, but individual SUs differ and may confer different risks of abnormally low blood sugar, or hypoglycemia. SUs-which include newer generation agents such as gliclazide, glipizide, glimepiride, and glibenclamide-stimulate the production of insulin in the pancreas and increase the effectiveness of insulin in the body.
After recent research from campaigning organization Greenpeace found the S-26 Soy brand of infant formula contains GM or genetically modified ingredients that are not disclosed on the product label, two Senators are urging the Federal Government to tighten Australia's food labeling laws.
A recent study published in the MDPI journal, Pathogens, describes a coronavirus peptide vaccine antigen in the form of nanodiamond-based formulations, that demonstrated a robust and long-lasting immune response. The nanodiamonds proved to be a powerful and versatile platform for antigen conjugation. This could make it a safe and effective strategy for the production of off-the-shelf vaccines against multiple coronaviruses.
A drug used for rheumatoid arthritis has moved a step closer to FDA approval for a desperately needed new use.
A Johns Hopkins study suggests that people with type I and type II diabetes would be well advised to monitor their blood sugar levels more than the usual twice daily to make sure that levels are not elevated over 150 milligrams per deciliter for sustained periods.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rajat Suri, MD Po Box 232410, San Diego, CA 92193-2410 Ph: () - | Dr Rajat Suri, MD 200 W Arbor Dr, San Diego, CA 92103-9000 Ph: (800) 926-8273 |
News Archive
Adding sulphonylureas (SUs) to metformin remains a commonly used strategy for treating type 2 diabetes, but individual SUs differ and may confer different risks of abnormally low blood sugar, or hypoglycemia. SUs-which include newer generation agents such as gliclazide, glipizide, glimepiride, and glibenclamide-stimulate the production of insulin in the pancreas and increase the effectiveness of insulin in the body.
After recent research from campaigning organization Greenpeace found the S-26 Soy brand of infant formula contains GM or genetically modified ingredients that are not disclosed on the product label, two Senators are urging the Federal Government to tighten Australia's food labeling laws.
A recent study published in the MDPI journal, Pathogens, describes a coronavirus peptide vaccine antigen in the form of nanodiamond-based formulations, that demonstrated a robust and long-lasting immune response. The nanodiamonds proved to be a powerful and versatile platform for antigen conjugation. This could make it a safe and effective strategy for the production of off-the-shelf vaccines against multiple coronaviruses.
A drug used for rheumatoid arthritis has moved a step closer to FDA approval for a desperately needed new use.
A Johns Hopkins study suggests that people with type I and type II diabetes would be well advised to monitor their blood sugar levels more than the usual twice daily to make sure that levels are not elevated over 150 milligrams per deciliter for sustained periods.
› Verified 5 days ago
Dr. Ramin Motarjemi, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 W Arbor Dr, San Diego, CA 92103 Phone: 858-249-2500 Fax: 858-657-8069 | |
Dr. Shweta Warner, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 4647 Zion Ave, San Diego, CA 92120 Phone: 619-221-6258 Fax: 619-221-6012 | |
Dr. Matthew James Roosevelt, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 4647 Zion Ave, Department Of Hospital Medicine, San Diego, CA 92120 Phone: 619-952-5091 | |
Dr. Daniel Joseph Desantis, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: Naval Medical Ctr, 34800 Bob Wilson Dr., San Diego, CA 92134 Phone: 619-532-7935 | |
Kris Kumar, Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 200 W Arbor Dr, San Diego, CA 92103 Phone: 800-926-8273 Fax: 888-539-8781 | |
Jedidiah Daniel Bell, Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 W Arbor Dr, San Diego, CA 92103 Phone: 619-471-0434 | |
Dr. Umber Dube, MD PHD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 8899 University Center Lane, Suite 350 Mc 0975, San Diego, CA 92122 Phone: 858-657-1675 |